Business Context and Reporting Period
Healthcare Triangle, Inc. filed a Form 8-K reporting a Nasdaq continued-listing deficiency. The earliest reported event occurred on June 3, 2022; the filing was signed June 10, 2022. The company’s common stock trades on Nasdaq under the symbol HCTI.
Financial Metrics
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Material Changes
- Nasdaq notified the company that its common stock had closed below the required minimum bid price of $1.00 per share for 30 consecutive business days.
- The deficiency relates to Nasdaq Listing Rule 5550(a)(2), the Bid Price Rule.
- The notice had no immediate effect on the company’s listing; HCTI remained listed on the Nasdaq Capital Market.
Outlook, Risks, and Contingencies
- The company received 180 calendar days, through November 30, 2022, to regain compliance.
- Compliance could be regained if the stock’s bid price closed at or above $1.00 for at least 10 consecutive business days before the deadline.
- The company might qualify for an additional 180-day period if it satisfies applicable market-value and other initial listing requirements and provides notice of its intention to cure the deficiency, potentially through a reverse stock split.
- If compliance is not regained, Nasdaq may issue a delisting notice. The company could then appeal to a Nasdaq hearings panel.
- Management stated that it was evaluating options, but the filing provides no assurance that compliance will be restored or that other Nasdaq requirements will remain satisfied.
Investor Verification Points
- Verify whether HCTI regained compliance by November 30, 2022 or obtained an additional compliance period.
- Check for any subsequent reverse stock split, delisting notice, appeal, or Nasdaq hearing decision.
- Review later filings for the company’s liquidity, capital needs, operating performance, and ability to maintain Nasdaq listing standards.